STATEMENT S ENTIRE GOODS

Brand Owner (click to sort) Address Description
AFLUNOV NOVARTIS INFLUENZA VACCINES MARBURG GMBH Emil-von-Behring-Str. 76 35041 Marburg Germany Statement(s): the entire goods, should be deleted, and pre-pandemic influenza vaccines for human use should be inserted.;[ pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system including diabetes and metabolic diseases, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, anti-bacterials, antivirals, antibiotics, anti-fungals, vaccines, diagnostic preparations for medical use ] * pre-pandemic influenza vaccines for human use *;
AFLUNOV Chiron Behring GmbH & Co. KG Emil-von-Behring-Strasse 76 35041 Marburg Germany Statement(s): the entire goods, should be deleted, and pre-pandemic influenza vaccines for human use should be inserted.;[ pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system including diabetes and metabolic diseases, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, anti-bacterials, antivirals, antibiotics, anti-fungals, vaccines, diagnostic preparations for medical use ] * pre-pandemic influenza vaccines for human use *;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A statement evaluation technique is based on bi-evaluation of programming statements. A programming language statement is evaluated that includes a first and a second sub-statement. The first sub-statement is evaluated and an evaluation success result is determined if evaluation succeeds, or a distinguished value if evaluation fails. The distinguished value is a value that is not included in the range of possible evaluation success results of the first sub-statement. Further, it is determined whether the second sub-statement is to be evaluated. If this is the case, an evaluation success result of the second sub-statement is determined if evaluation succeeds, or the distinguished value if evaluation fails. The range of possible evaluation success results of the second sub-statement does not include the distinguished value. The evaluation result of the statement is determined depending on at least whether evaluation of the first sub-statement succeeds or fails.